SPIEGEL, B
1058  Ergebnisse:
Personensuche X
?
1

Polarizing or paralyzing? Moving forward with patient repor..:

Spiegel, B.
Revista de Gastroenterología de México.  78 (2013)  1 - p. 1-4 , 2013
 
?
2

The yield and cost of colonoscopy in patients with metastat..:

Saliminejad, M. ; Bemanian, S. ; Ho, A...
Alimentary Pharmacology & Therapeutics.  38 (2013)  6 - p. 628-633 , 2013
 
?
4

Setting priorities for comparative effectiveness research i..:

Cheifetz, A. S. ; Melmed, G. Y. ; Spiegel, B....
Inflammatory Bowel Diseases.  18 (2012)  12 - p. 2294-2300 , 2012
 
?
5

Direct Medical Care Costs Among Pegylated Interferon Plus R..:

Solomon, M. ; Bonafede, M. ; Pan, K....
Digestive Diseases and Sciences.  56 (2011)  10 - p. 3024-3031 , 2011
 
?
6

Two weeks of rifaximin relieves global symptoms and bloatin..:

Spiegel, B.
Evidence-Based Medicine.  16 (2011)  5 - p. 156-157 , 2011
 
?
8

Measuring irritable bowel syndrome patient‐reported outcome..:

SPIEGEL, B. ; BOLUS, R. ; HARRIS, L. A....
Alimentary Pharmacology & Therapeutics.  30 (2009)  11-12 - p. 1159-1170 , 2009
 
?
9

Systematic review: the prevalence of suicidal behaviour in ..:

SPIEGEL, B. ; SCHOENFELD, P. ; NALIBOFF, B.
Alimentary Pharmacology & Therapeutics.  26 (2007)  2 - p. 183-193 , 2007
 
?
 
?
12

Different Approaches in the Tanaitic Literature Regarding t..:

שפיגל, בעז ; Spiegel, B.
Shenaton ha-Mishpat ha-Ivri: Annual of the Institute for Research in Jewish Law / שנתון המשפט העברי של המכון לחקר המשפט העברי.  כג (2005)  - p. 351-382 , 2005
 
?
 
?
15

Geeignete Designs für typische Fragestellungen:

, In: Good Clinical Practice II; Konzepte in der Humanpharmakologie,
Spiegel, B. - p. 33-41 , 1992
 
1-15